Pharmacokinetics – Medgate Today

Home / Posts Tagged "Pharmacokinetics"

Zydus Lifesciences Limited Financial Performance for Q3 FY25 Revenue from operations at Rs. 52,691 mn, up 17% YoY Net Profit at Rs. 10,235 mn, up 30% YoY

February 6, 2025

5:09 am

Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and nine months ended December 31st, 2024. Key Financial Highlights Q3 FY25 Highlights Revenue from operations at Rs. 52,691 mn, up 17% over last year. Research & Development (R&D) investments for the quarter stood

POST TAGS:

Syngene reports third quarter results: revenue from operations up 9% to Rs 854 crores, PAT up 4% to Rs 115 crores

January 27, 2024

6:08 am

News Update

admin

Company reports resilient performance in the nine months to date: revenue from operations up 17% to Rs 2,572 crores, PAT up 16% to Rs 330 crores (before exceptional items) Syngene International Limited today announced its third quarter financial results. Reported revenue from operations for the quarter

POST TAGS:

Biologics Jonathan Hunt Pharma Pharmacokinetics Revenue Sibaji Biswas Stelis Biopharma Syngene

Zydus Lifesciences Limited Financial Performance for Q3 FY25 Revenue from operations at Rs. 52,691 mn, up 17% YoY Net Profit at Rs. 10,235 mn, up 30% YoY

POST TAGS:

Syngene reports third quarter results: revenue from operations up 9% to Rs 854 crores, PAT up 4% to Rs 115 crores

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA